FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

385275000: forme pharmaceutique pour usage transdermique et/ou cutané (valeur de l'attribut)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    436351000077118 forme pharmaceutique pour usage transdermique et/ou cutané (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form est un(e) (attribut) type de préparation médicamenteuse false Inferred relationship Some
    Cutaneous AND/OR transdermal dosage form est un(e) (attribut) Dose form by site prepared for false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Nystatin + triamcinolone acetonide 100000unt/1mg cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Nystatin + triamcinolone acetonide 100000unt/1mg ointment (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Nystatin + triamcinolone acetonide 10000unt/1mg ointment (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Norelgestromin+ethinyl estradiol 6mg/0.75mg patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Pimecrolimus 1% cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing amphotericin in topical dosage form (medicinal product form) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Cleocin t 10mg/ml lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Clonidine-containing product in transdermal dose form a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing tacrolimus in topical dosage form (medicinal product form) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing betamethasone and calcipotriol (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Methyl aminolevulinate 168mg/g topical cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing lidocaine and tetracaine (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Lidocaine 70mg/tetracaine 70mg transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Metronidazole 10 mg/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dapsone 50 mg/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Griseofulvin 10 mg/mL cutaneous spray a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous spray (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing ichthammol and zinc oxide (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing benzoyl peroxide and clindamycin (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing calamine and dibrompropamidine (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing desoximetasone and salicylic acid (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing methyl nicotinate (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing diethylamine salicylate (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing 9 cis-octadecenoic acid and turpentine oil (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Selegiline 6mg/24hours transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Selegiline 9mg/24hours transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Selegiline 12mg/24hours transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Pyrethrin 0.33%/4% piperonyl butoxide topical aerosol mousse (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely ciclopirox 10 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Ketoconazole 20 mg/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Desonide 500 microgram/mL cutaneous foam a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Lidocaine 2.5% topical ointment (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Diphenhydramine 2%/zinc acetate 0.1% topical cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Desonide 500 microgram/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing testosterone in topical dosage form (medicinal product form) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Catechin 15% topical ointment (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    médicament contenant clindamycine et trétinoïne a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Clindamycin 1.2%/tretinoin 0.025% topical gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Iodine 0.7%/isopropyl alcohol 74% w/w topical solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing terbinafine in topical dosage form (medicinal product form) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    capsaïcine a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 30% bath emulsion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Lignocaine 5% / Hydrocortisone acetate 0.275% ointment (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Norethisterone 170micrograms/24hours / Estradiol 50micrograms/24hours patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Hydrocortisone 1% + Pramocaine 1% foam enema (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Estradiol 1.25g/dose gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Testosterone 15mg transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid 20% 7.5cmx4.5cm plaster (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid 40% 7.5cmx4.5cm plaster (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Enbucrilate 500mg tissue adhesive (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Cutaneous ointment est un(e) (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Gamolenic acid 20% cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Retapamulin 10 mg/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Biological active component 2mL vial/thrombin sealant solution 2mL vial (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Evening primrose oil 20% cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Triamcinolone acetonide 1 mg/mL cutaneous lotion a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 10 mg/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Polynoxylin 100 mg/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Biological active component 5mL vial/thrombin sealant solution 5mL vial (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing polynoxylin (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Biological active component 1mL vial/thrombin sealant solution 1mL vial (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing glycol salicylate and methyl nicotinate (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Diclofenac epolamine 1.3% transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Rotigotine 4mg/24hours transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Rotigotine 2mg/24hours transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Estradiol 0.25mg/dose topical gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Rotigotine 6mg/24hours transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Avobenzone 2%/ecamsule 3%/octocrilene 10% topical cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Miscellaneous topical minor anti-infective (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Avobenzone 2%/ecamsule 2%/octocrilene 10% topical cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing acetic acid and turpentine oil (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Rivastigmine 4.6mg/24 hours transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing terebene (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Rivastigmine 9.5mg/24 hours transdermal patch (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Adapalene 3 mg/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing tar oil (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Estradiol 1.53mg transdermal spray a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing turpentine oil (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing rectified birch tar oil (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing rectified pine tar oil (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Human thrombin topical solution 5mL vial (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Human thrombin topical solution 20mL vial (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing alkali-metal soap and camphor and turpentine oil (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing alpha-pinene (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous foam (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Human thrombin topical solution 2mL vial (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing pinene (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Pinene hydrochloride (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing camphene (medicinal product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Bovine thrombin 5000iu powder for topical solution + 5mL vial diluent (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Bovine thrombin 20000iu powder for topical solution + 20mL vial diluent (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some

    Start Previous Page 10 of 13 Next End


    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start